+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Clinical trials for stem cell therapies

Clinical trials for stem cell therapies

Bmc Medicine 9: 52

In recent years, clinical trials with stem cells have taken the emerging field in many new directions. While numerous teams continue to refine and expand the role of bone marrow and cord blood stem cells for their vanguard uses in blood and immune disorders, many others are looking to expand the uses of the various types of stem cells found in bone marrow and cord blood, in particular mesenchymal stem cells, to uses beyond those that could be corrected by replacing cells in their own lineage. Early results from these trials have produced mixed results often showing minor or transitory improvements that may be attributed to extracellular factors. More research teams are accelerating the use of other types of adult stem cells, in particular neural stem cells for diseases where beneficial outcome could result from either in-lineage cell replacement or extracellular factors. At the same time, the first three trials using cells derived from pluripotent cells have begun.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 036087881

Download citation: RISBibTeXText

PMID: 21569277

DOI: 10.1186/1741-7015-9-52

Related references

Perspectives on human clinical trials of therapies using iPS cells in Japan: reaching the forefront of stem-cell therapies. Bioscience Trends 7(3): 157-158, 2013

Stem Cell Therapies in Clinical Trials: Progress and Challenges. Cell Stem Cell 17(1): 11-22, 2015

Stem cell therapies for chronic obstructive pulmonary disease: current status of pre-clinical studies and clinical trials. Journal of Thoracic Disease 10(2): 1084-1098, 2018

Regulated and Unregulated Clinical Trials of Stem Cell Therapies for Stroke. Translational Stroke Research 8(2): 93, 2017

Stem cell therapies in clinical trials: workshop on best practices and the need for harmonization. Cell Stem Cell 7(4): 451-454, 2010

Current clinical trials of cell-based therapies in cardiac repair: too many variables spoil the stem cell broth. European Heart Journal 35(15): 955-957, 2014

StemCells, Inc.: Clinical trials of stem cell therapies for CNS disorders. Interview with Martin McGlynn. Regenerative Medicine 7(6 Suppl): 8, 2012

Allowing innovative stem cell-based therapies outside of clinical trials: ethical and policy challenges. Journal of Law Medicine and Ethics 38(2): 277-285, 2010

Stem cell therapies for Type 1 diabetes: current status and proposed road map to guide successful clinical trials. Diabetic Medicine 36(3): 297-307, 2019

Stem cell-based therapies for multiple sclerosis: recent advances in animal models and human clinical trials. Regenerative Medicine 9(2): 129-132, 2014

Safety and effectiveness of stem cell therapies in early-phase clinical trials in stroke: a systematic review and meta-analysis. Stem Cell Research and Therapy 8(1): 191, 2017

Current status and perspectives on stem cell-based therapies undergoing clinical trials for regenerative medicine: case studies. British Medical Bulletin 108: 73-94, 2013

Concise Review: Lessons Learned from Islet Transplant Clinical Trials in Developing Stem Cell Therapies for Type 1 Diabetes. Stem Cells Translational Medicine 8(3): 209-214, 2019

Reporting of adverse event data in hematopoietic stem cell transplantation clinical trials involving investigational new drugs or devices: a report from the William Guy Forbeck Foundation 2001 focus meeting on clinical trials in hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation 8(6): 295-302, 2002

Stem cell therapies for Parkinson's disease: are trials just around the corner?. Regenerative Medicine 9(5): 553-555, 2014